Eli Lilly Sales Jump to Record $3.4 Billion

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

  • VIDEO TEXT

July 24 (Bloomberg) -- Bloomberg's Olivia Sterns discusses Eli Lilly earnings and the possibility of the company falling off the patent cliff in December. She speaks to Mark Crumpton on Bloomberg Television's "Bottom Line." (Source: Bloomberg)

Good news for lily today.

What was the key take away for their earnings?

They beat on both the top and bottom line.

The real reason we saw saw shares move today is because the company raised their guides for the rest of the year.

That is surprising because eli lilly is a company on the brink of falling off a patent cliff.

The best drug is a depression blockbuster worth about $5 billion in sales.

They lose that at the end of the year.

What is in the pipeline now is really mattering for the future of growth.

What did you get to see?

This has to be a fascinating behind us means look very it is extraordinary.

A lot of fun.

Experts from all around the world.

We focus on diabetes and alzheimer's. diabetes particularly will be a growth driver.

Showing me an incredible syringe, they are coming up with all these new solutions that make it easier for people to live with diabetes.

They have four compounds.

A pretty hefty pipeline.

They are hoping to regain leadership.

Also taking a big bet on alzheimer's. yes.

They are actually in the lead on alzheimer's research.

The big drug they are betting on, they have been working on alzheimer's for 25 years.

They have still not come up with anything that works.

When i spoke to the ceo today, i put the question to him, how far away do you really think we are now from finding something that actually works for alzheimer's. when you get into the large phase three study, they tend to be more expensive.

We benefited along the way from a lot of new knowledge, new clues,, and new learnings about alzheimer's disease.

I have to believe in the next 10 years, our industry will begin to close in on our cameras.

Fax it does feel to a lot of investors like a lottery ticket investment.

If you can be the first big company to something that actually works, treating the causes and not just the symptoms, there could be a huge potential payout because of the unmet medical need.

They have been added for a quarter of a century.

What what did he have to say about china?

I put this question to him.

These allegations of what is going on do seem to be industrywide in the

This text has been automatically generated. It may not be 100% accurate.

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change